Netherlands Pharmacovigilance Centre Lareb, WHO Collaborating Centre For Pharmacovigilance in Education and Patient Reporting, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.
University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, PO Box 196, Groningen, 9700 AD, The Netherlands.
Drug Saf. 2018 Nov;41(11):1003-1011. doi: 10.1007/s40264-018-0681-z.
Adverse drug reactions (ADRs) can cause serious health problems, as shown in studies about drug-related hospitalizations. To build knowledge of and raise awareness about ADRs among healthcare professionals, more education in the field of ADRs and pharmacovigilance (PV) is needed. No standard exists for teaching PV at universities for medical, pharmacy, dentistry and nursing students, so a core curriculum needs to be developed to teach important aspects of PV to students. In September 2016, a stakeholders' meeting was initiated on behalf of the World Health Organization (WHO) and organized by the Netherlands Pharmacovigilance Centre Lareb. This meeting addressed and agreed on the PV competencies students need to develop and what key aspects of the subject should be taught. Five key aspects were identified: understanding the importance of PV in the context of pharmacotherapy, and preventing, recognizing, managing and reporting ADRs. Since time and resources for PV education are limited, elements of the WHO PV core curriculum for university teaching were designed to be integrated into existing courses but can be used as a stand-alone programme. The basis of and outline for the WHO PV core curriculum for university teaching are addressed in this paper. It is expected that PV competencies for students are vital for their contribution to safe use of medicines in the future. In addition, this article aims to stimulate discussion on this subject and promote collaboration between universities, national PV centres and other stakeholders to integrate key aspects of PV in their educational programmes.
药物不良反应（ADR）可导致严重的健康问题，这在与药物相关的住院研究中有所体现。为了增进医疗保健专业人员对 ADR 的了解和认识，需要在 ADR 和药物警戒（PV）领域提供更多的教育。目前，医科、药学、牙科学和护理学学生在大学中没有药物警戒教学的标准，因此需要制定核心课程，向学生传授药物警戒的重要方面。2016 年 9 月，代表世界卫生组织（WHO）发起了一次利益攸关方会议，由荷兰药物警戒中心 Lareb 组织。此次会议讨论并商定了学生需要发展的 PV 能力，以及应该教授该学科的哪些关键方面。确定了五个关键方面：在药物治疗学背景下理解 PV 的重要性，以及预防、识别、管理和报告 ADR。由于 PV 教育的时间和资源有限，WHO 大学教学药物警戒核心课程的元素被设计成融入现有课程，但也可以作为独立的课程使用。本文介绍了 WHO 大学教学药物警戒核心课程的基础和大纲。预计学生的 PV 能力对于他们未来为安全用药做出贡献至关重要。此外，本文旨在就这一主题展开讨论，并促进大学、国家药物警戒中心和其他利益攸关方之间的合作，将药物警戒的关键方面纳入其教育计划。
